BI 882370 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. Its application focuses on targeting specific pathways involved in tumor growth and proliferation. Researchers employ this compound to investigate its potential as an inhibitor of certain proteins or enzymes that play a critical role in cancer cell survival. By doing so, it aids in understanding the mechanisms of cancer progression and evaluating its efficacy as a therapeutic agent. Additionally, BI 882370 is used in preclinical studies to assess its pharmacokinetics, safety profile, and potential side effects, which are essential steps in the development of new anticancer drugs. Its role in advancing targeted therapy research makes it a valuable tool in the ongoing fight against cancer.